4AT7
 
 | | Crystal structure of the NF90-NF45 dimerisation domain complex | | Descriptor: | DI(HYDROXYETHYL)ETHER, INTERLEUKIN ENHANCER-BINDING FACTOR 2, INTERLEUKIN ENHANCER-BINDING FACTOR 3, ... | | Authors: | Wolkowicz, U.M, Cook, A.G. | | Deposit date: | 2012-05-05 | | Release date: | 2012-08-01 | | Last modified: | 2024-05-01 | | Method: | X-RAY DIFFRACTION (1.902 Å) | | Cite: | NF45 Dimerizes with NF90, Zfr and Spnr Via a Conserved Domain that Has a Nucleotidyltransferase Fold.
Nucleic Acids Res., 40, 2012
|
|
4AT8
 | |
4ATB
 | |
4AT9
 | |
4MDB
 | | Structure of Mos1 transposase catalytic domain and Raltegravir with Mg | | Descriptor: | MAGNESIUM ION, Mariner Mos1 transposase, N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di hydropyrimidine-4-carboxamide | | Authors: | Richardson, J.M. | | Deposit date: | 2013-08-22 | | Release date: | 2014-01-22 | | Last modified: | 2023-09-20 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | Structural Basis of Mos1 Transposase Inhibition by the Anti-retroviral Drug Raltegravir.
Acs Chem.Biol., 9, 2014
|
|
4MDA
 | | Structure of Mos1 transposase catalytic domain and Raltegravir with Mn | | Descriptor: | MANGANESE (II) ION, Mariner Mos1 transposase, N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di hydropyrimidine-4-carboxamide | | Authors: | Richardson, J.M. | | Deposit date: | 2013-08-22 | | Release date: | 2014-01-22 | | Last modified: | 2023-09-20 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | Structural Basis of Mos1 Transposase Inhibition by the Anti-retroviral Drug Raltegravir.
Acs Chem.Biol., 9, 2014
|
|
